Wei, Y., Corchete Sánchez, L. A., Mathavarajah, S., Antelo, D., Wang, S., Lee, J., Weissman, A. D., Kannambadi, D. D., Qin, Q., Danielli, S. G., Quantin, E. J., Eng, T. C., Bacquelaine Veloso, A., Wang, Y., Neilsen, G. P., Yan, C., Yang, V. S., Patel, A. G., Koo, S. C., ... Langenau, D. M. (2026). MYOD1 mutation drives cancer stem cell pathways and therapy-resistance in spindle cell/sclerosing rhabdomyosarcoma. Nature Communications. doi:10.1038/s41467-026-73546-7 |
Van Aerschot, L., Demeyer, S., Timcheva, K., Heylen, E., Verstraete, P., De Groote, D., Caruso, M., Lauwereins, L., Bacquelaine Veloso, A., Kampen, K. R., Pepe, D., Boeckx, N., Royaert, J., Verbeeck, J., Segers, H., Cools, J., De Keersmaecker, K., & Granados, D. C. (2026). NKX2-1 regulates cell survival, maturation, and DNA-damage responses as a cofactor of RUNX1 in T-cell acute lymphoblastic leukemia. Haematologica. doi:10.3324/haematol.2025.287966 |
Lauwereins, L., Van Thillo, Q., Demeyer, S., Mentens, N., Provost, S., Jacobs, K., Gielen, O., Boogaerts, L., de Bock, C. E., Andrieu, G., Asnafi, V., Cools, J., & Bacquelaine Veloso, A. (March 2025). TLE4 is a repressor of the oncogenic activity of TLX3 in T-cell acute lymphoblastic leukemia. Leukemia, 39 (3), 568 - 576. doi:10.1038/s41375-025-02513-w |
Cardoso, B. A., Duque, M., Gírio, A., Fragoso, R., Oliveira, M. L., Allen, J. R., Martins, L. R., Correia, N. C., Silveira, A. B., Bacquelaine Veloso, A., Kimura, S., Demoen, L., Matthijssens, F., Jeha, S., Cheng, C., Pui, C.-H., Grosso, A. R., Neto, J. L., De Almeida, S. F., ... Barata, J. T. (01 June 2024). CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia. Haematologica, 109 (6), 1713 - 1725. doi:10.3324/haematol.2023.282854 |
Veloso, A.* , Bleuart, A.* , Conrard, L., Orban, T., Bruyr, J., Cabochette, P., Germano, R. F. V., Schevenels, G., Bernard, A., Zindy, E., Demeyer, S., Vanhollebeke, B., Dequiedt, F.* , & Martin, M.*. (27 February 2024). The cytoskeleton adaptor protein Sorbs1 controls the development of lymphatic and venous vessels in zebrafish. BMC Biology, 22 (1), 51. doi:10.1186/s12915-024-01850-z * These authors have contributed equally to this work. |
Bacquelaine Veloso, A., & Cools, J. (20 July 2023). Targeting STAT5B in T-cell acute lymphoblastic leukemia. Blood, 142 (3), 215 - 217. doi:10.1182/blood.2023020639 |
Laukkanen, S.* , Bacquelaine Veloso, A.* , Yan, C., Oksa, L., Alpert, E. J., Do, D., Hyvärinen, N., McCarthy, K., Adhikari, A., Yang, Q., Iyer, S., Garcia, S. P., Pello, A., Ruokoranta, T., Moisio, S., Adhikari, S., Yoder, J. A., Gallagher, K., Whelton, L., ... Langenau, D. M.*. (27 October 2022). Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia. Blood, 140 (17), 1891 - 1906. doi:10.1182/blood.2021015106 * These authors have contributed equally to this work. |
Oliveira, M. L., Bacquelaine Veloso, A., Garcia, E. G., Iyer, S., Pereira, C., Barreto, V. M., Langenau, D. M., & Barata, J. T. (June 2022). Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia. Leukemia, 36 (6), 1533 - 1540. doi:10.1038/s41375-022-01590-5 |
Yan, C., Yang, Q., Zhang, S., Millar, D. G., Alpert, E. J., Do, D., Bacquelaine Veloso, A., Brunson, D. C., Drapkin, B. J., Stanzione, M., Scarfò, I., Moore, J. C., Iyer, S., Qin, Q., Wei, Y., McCarthy, K. M., Rawls, J. F., Dyson, N. J., Cobbold, M., ... Langenau, D. M. (04 October 2021). Single-cell imaging of T cell immunotherapy responses in vivo. Journal of Experimental Medicine, 218 (10). doi:10.1084/jem.20210314 |
Garcia, E. G., Bacquelaine Veloso, A., Oliveira, M. L., Allen, J. R., Loontiens, S., Brunson, D., Do, D., Yan, C., Morris, R., Iyer, S., Garcia, S. P., Iftimia, N., Van Loocke, W., Matthijssens, F., McCarthy, K., Barata, J. T., Speleman, F., Taghon, T., Gutierrez, A., ... Langenau, D. M. (March 2021). PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis. Leukemia, 35 (3), 679 - 690. doi:10.1038/s41375-020-0937-3 |
Veloso, A., Martin, M., Bruyr, J., O'Grady, T., Deroanne, C., Mottet, D., Twizere, J.-C., Cherrier, T.* , & Dequiedt, F.*. (2019). Dephosphorylation of HDAC4 by PP2A-Bdelta unravels a new role for the HDAC4/MEF2 axis in myoblast fusion. Cell Death and Disease, 10 (7), 512. doi:10.1038/s41419-019-1743-6 * These authors have contributed equally to this work. |
Martin, M., Bacquelaine Veloso, A., Wu, J., Katrukha, E. A., & Akhmanova, A. (16 March 2018). Control of endothelial cell polarity and sprouting angiogenesis by non-centrosomal microtubules. eLife, 7. doi:10.7554/eLife.33864 |
Bacquelaine Veloso, A., Slegers, T., Schoenaker, J., Demeyer, S., den Bergh, S. V., Aertgeerts, M., Verhoeft, K., Schoenmaekers, Y., Meeuws, N., Bischops, I., Renard, F., Boogaerts, L., Mentens, N., Gielen, O., Jacobs, K., Segers, H., Cools, J., Dierickx, D., & Bempt, M. V. (2024). Dual targeting of EZH2 and Histone Deacetylases in hematological malignancies promotes transcriptional and metabolic deregulation leading to ferroptosis. BioRxiv. doi:10.1101/2024.03.03.583195 |